ABVC (ABVC BioPharma) 10-Year Sharpe Ratio: -0.38 (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ABVC ABVC BioPharma Inc ABVC
21 GF Score
Price $0.86
! 1 Warning Sign
View Full Analysis

What is ABVC BioPharma 10-Year Sharpe Ratio?

ABVC BioPharma ABVC +3.52% 21 10-Year Sharpe Ratio is -0.38 as of Sep. 02, 2026. GuruFocus rates ABVC with a GF Score™ of 21/100. The stock has 1 warning sign investors should review.

The 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. As of today (2026-09-02), ABVC BioPharma's 10-Year Sharpe Ratio is -0.38.

ABVC BioPharma  (NAS:ABVC) 10-Year Sharpe Ratio Explanation

The 10-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past ten years. It is calculated as the annualized result of the average ten-year monthly excess returns divided by its standard deviation in the ten-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

ABVC BioPharma 10-Year Sharpe Ratio Related Terms

ABVC vs ALLR, MRKR, CNSY: 10-Year Sharpe Ratio Comparison

For the Biotechnology subindustry, ABVC BioPharma's 10-Year Sharpe Ratio, along with its competitors' market caps and 10-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABVC BioPharma 10-Year Sharpe Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ABVC BioPharma's 10-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where ABVC BioPharma's 10-Year Sharpe Ratio falls into.


ABVC
21GF Score
ABVC BioPharma Inc ABVC
10-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ABVC BioPharma 10-Year Sharpe Ratio Calculation

The 10-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last ten years. A stock / portfolio's 10-Year Sharpe Ratio can be calculated by dividing the difference between the ten-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past ten years.

Frequently Asked Questions Learn more about 10-Year Sharpe Ratio →
What does a 10-Year Sharpe Ratio of -0.38 mean?
ABVC BioPharma (ABVC) has a 10-Year Sharpe Ratio of -0.38 as of Sep. 02, 2026. 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. View historical data for ABVC BioPharma and its competitors.
Is ABVC BioPharma's 10-Year Sharpe Ratio too high?
ABVC BioPharma's current 10-Year Sharpe Ratio is -0.38. Overall, ABVC BioPharma has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does ABVC BioPharma's 10-Year Sharpe Ratio compare to ALLR and MRKR?
ABVC BioPharma's 10-Year Sharpe Ratio of -0.38 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Sharpe Ratio for a Biotechnology company?
A good 10-Year Sharpe Ratio depends on the Biotechnology industry context. However, 10-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Sharpe Ratio mean?
A high 10-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. View historical data for ABVC BioPharma and its competitors. ABVC BioPharma's current 10-Year Sharpe Ratio is -0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABVC BioPharma stock overvalued right now?
ABVC BioPharma (ABVC) has a current 10-Year Sharpe Ratio of -0.38. The current 10-Year Sharpe Ratio is -0.38. ABVC BioPharma's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Sharpe Ratio calculated?
10-Year Sharpe Ratio is calculated from a company's financial statements. For ABVC BioPharma (ABVC), the current 10-Year Sharpe Ratio is -0.38 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ABVC BioPharma Business Description

Address 44370 Old Warm Springs Boulevard, Fremont, CA, USA, 94538
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
21GF Score

Get the complete analysis for ABVC

10-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.86
Price